Prescription drug · ANDA
Progesterone NDC 50090-6771
Progesterone 100 mg/1 · Capsule · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6771-0 | 50090677100 | 10 CAPSULE in 1 BOTTLE (50090-6771-0)Marketed from Oct 23, 2023 | |
| 50090-6771-1 | 50090677101 | 90 CAPSULE in 1 BOTTLE (50090-6771-1)Marketed from Oct 23, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Progesterone
- Generic name (nonproprietary)
- progesterone
- Active ingredients
- Progesterone — 100 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 200900
- Marketing start
- Listing expires
- Other FDA classes
- Progesterone (Chemical structure)
- Identifiers
- Product ID 50090-6771_252d6b70-6655-4f98-9646-15ce6fc82eccSPL ID 252d6b70-6655-4f98-9646-15ce6fc82eccSPL set ID 566584fc-c76a-4e42-a62e-109a2903b939RxCUI 260243UNII 4G7DS2Q64Y
- Pharmacologic class
- Progesterone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090677100followed by a unit qualifier and the quantityPackage 50090-6771-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 200900
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-981 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-980 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2242 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-148 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-149 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Proficient Rx LP | 82804-268 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-3529 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-233 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8709 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-234 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8719 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-3557 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4166 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-9739 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Asclemed USA, Inc. | 76420-582 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Asclemed USA, Inc. | 76420-580 |